Gennev presents menopause care as a clinic appointment rather than a single estrogen subscription. A physician visit may lead to hormonal medicine, a nonhormonal option, a dietitian referral or another plan. That makes the scope of the appointment as important as the price of any resulting prescription.
This review uses Gennev’s service and insurance pages retrieved September 28, 2026. It examines the published structure, not care we received. We did not book a slot, verify a particular insurance policy or measure the company’s advertised symptom outcomes.
Gennev publishes a menopause consultation service and self-pay visit fees; its integrated-care language does not make medication, nutrition visits or outcomes automatic.
The appointment is the core unit of care
The Gennev homepage describes 30-minute video appointments with menopause-trained, board-certified doctors. It also describes a free account, medical-history questionnaire and selection of a payment method before booking. Those steps establish a consultation pathway, not permission to select a hormone without assessment.
Gennev advertises visits within a week and availability across all 50 states. These are public service claims rather than a live appointment search performed for this review. Confirm the clinician’s availability where you will physically attend the visit. The distinction from Winona’s asynchronous service is meaningful for someone who needs a scheduled conversation, but neither communication format is a clinical quality score.
Estrogen is one possible result, not the whole catalog
The insurance and pricing page explicitly describes FDA-approved hormonal and nonhormonal treatments. It says the clinical team reviews health history and symptoms before deciding whether hormonal medication is appropriate. A broad list of menopause complaints should not be read as a promise that estrogen addresses every listed concern.
The public pages reviewed here did not establish a complete selectable estrogen formulary with exact manufacturers, strengths and pharmacy prices. Our local versus systemic estrogen guide explains why the intended symptom and specific preparation need to be identified together. A consultation that ends with a nonhormonal option or referral can still fall within the published service description; purchasing the visit does not buy a guaranteed prescription.
The doctor and dietitian prices should stay separate
Gennev’s current pricing table lists a self-pay initial doctor visit at $250 and a follow-up doctor visit at $199. It separately lists an initial registered dietitian nutritionist appointment at $199 and a follow-up at $119. The doctor visits are described as 30 minutes; dietitian appointments have their own longer initial and shorter follow-up durations.
These figures identify different professional services. They are not a combined monthly package and should not be added into a mandatory course that the source does not prescribe. Ask which visits are proposed and why, whether a referral is involved, and how the next appointment will be billed. The eventual medication and any outside testing need their own cost confirmation.
An insurance estimate can change after the claim
Gennev’s billing explanation says care coordinators estimate the copay, coinsurance or deductible after receiving insurance information. The company collects the estimated patient portion, submits the remaining claim and may send a further statement after the insurer processes it. The insurance table therefore does not establish a guaranteed final bill.
Coverage also has a visit-count dimension: the page says the number of covered appointments depends on the plan. Confirm whether doctor and dietitian appointments draw on different benefits or limits. Stella’s review provides another visit-based comparison, while MyMenopauseRx illustrates why the insurer’s allowed charge can matter when a deductible is unmet. A familiar carrier name alone does not settle any of those questions.
A pharmacy handoff requires a second confirmation
Gennev says prescriptions can be sent to the patient’s pharmacy when needed. That is distinct from a bundled shipment of estrogen from the provider. A same-day prescription transmission claim does not verify that the pharmacy has the drug, that a prior authorization is complete or that the medication is ready for pickup.
Ask which preparation the clinician intends, how the pharmacy will communicate a substitution or coverage problem, and who handles a request for clarification. Our patch-versus-pill discussion supplies route questions without choosing a route for the reader. Keeping the visit invoice beside the pharmacy quotation prevents a low consultation copay from being mistaken for the total cost of ongoing care.
Integrated support does not erase medical boundaries
Gennev describes doctors and dietitians working together on medical and lifestyle care. Its page says a dietitian referral is made when clinically indicated. That collaboration may be useful, but a nutrition appointment should not be assumed to perform the same work as a prescribing visit or an in-person examination.
The site also highlights patient recommendation and relief statistics. We did not independently evaluate their sampling, follow-up or causal interpretation, so they are not used here to rank outcomes. FDA’s menopause guidance retains the need to weigh hormone benefits and risks individually. If systemic estrogen is proposed, the progesterone question belongs in the medical conversation rather than being left to a general wellness plan.
Leave the first visit with a defined next contact
A useful Gennev consultation record would identify what was assessed, what is being prescribed or deferred, which professional follows each issue and when the next contact is expected. The public pricing page says follow-up may be booked when hormones or other medicines are prescribed, but it does not establish one universal schedule for every patient.
The questions-before-starting guide can help organize those gaps. Ask how a new symptom, pharmacy problem or need for local examination changes the plan. Gennev is a documented option for virtual menopause appointments; a published national footprint and specialist description remain separate from verified access for an individual, an affordable final claim and an appropriate long-term prescription.
Sources & reading
Source check dates appear with each record below. Provider pages describe their own services; they do not establish clinical superiority.
- Gennev: virtual menopause care ↗Provider service page; national access, visit timing and outcomes are company statements, not tested · Checked 2026-09-28
- Gennev: insurance and pricing ↗Provider visit-price and insurance-process record; pharmacy and individual claims are separate · Checked 2026-09-28
- FDA: Menopause ↗Current federal patient guidance; individualized benefits/risks and prevention limits, no class-wide labeling-change inference · Checked 2026-09-28